Biokarpet Statistics

Total Valuation

Biokarpet has a market cap or net worth of EUR 44.73 million. The enterprise value is 147.72 million.

Market Cap	44.73M
Enterprise Value	147.72M

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	Aug 26, 2024

Share Statistics

Biokarpet has 23.99 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	23.99M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	40.01%
Owned by Institutions (%)	11.04%
Float	14.39M

Valuation Ratios

The trailing PE ratio is 13.40.

PE Ratio	13.40
Forward PE	n/a
PS Ratio	0.23
PB Ratio	0.92
P/TBV Ratio	0.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.32, with an EV/FCF ratio of -11.38.

EV / Earnings	44.24
EV / Sales	0.75
EV / EBITDA	11.32
EV / EBIT	20.63
EV / FCF	-11.38

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 2.21.

Current Ratio	1.73
Quick Ratio	1.09
Debt / Equity	2.21
Debt / EBITDA	8.61
Debt / FCF	-8.43
Interest Coverage	0.98

Financial Efficiency

Return on equity (ROE) is 7.07% and return on invested capital (ROIC) is 2.69%.

Return on Equity (ROE)	7.07%
Return on Assets (ROA)	2.04%
Return on Capital (ROIC)	2.69%
Revenue Per Employee	293,020
Profits Per Employee	4,962
Employee Count	676
Asset Turnover	0.95
Inventory Turnover	4.69

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.10% in the last 52 weeks. The beta is 0.99, so Biokarpet's price volatility has been similar to the market average.

Beta (5Y)	0.99
52-Week Price Change	-34.10%
50-Day Moving Average	1.78
200-Day Moving Average	2.24
Relative Strength Index (RSI)	58.23
Average Volume (20 Days)	13,122

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biokarpet had revenue of EUR 197.20 million and earned 3.34 million in profits. Earnings per share was 0.14.

Revenue	197.20M
Gross Profit	31.67M
Operating Income	6.81M
Pretax Income	4.89M
Net Income	3.34M
EBITDA	11.45M
EBIT	6.81M
Earnings Per Share (EPS)	0.14

Full Income Statement

Balance Sheet

The company has 7.15 million in cash and 109.33 million in debt, giving a net cash position of -102.18 million or -4.26 per share.

Cash & Cash Equivalents	7.15M
Total Debt	109.33M
Net Cash	-102.18M
Net Cash Per Share	-4.26
Equity (Book Value)	49.42M
Book Value Per Share	2.03
Working Capital	45.38M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.31 million and capital expenditures -16.29 million, giving a free cash flow of -12.98 million.

Operating Cash Flow	3.31M
Capital Expenditures	-16.29M
Free Cash Flow	-12.98M
FCF Per Share	-0.54

Full Cash Flow Statement

Margins

Gross margin is 16.06%, with operating and profit margins of 3.46% and 1.69%.

Gross Margin	16.06%
Operating Margin	3.46%
Pretax Margin	2.48%
Profit Margin	1.69%
EBITDA Margin	5.80%
EBIT Margin	3.46%
FCF Margin	n/a

Dividends & Yields

Biokarpet does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	7.46%
FCF Yield	-29.01%

Dividend Details

Stock Splits

The last stock split was on March 15, 2000. It was a forward split with a ratio of 2.

Last Split Date	Mar 15, 2000
Split Type	Forward
Split Ratio	2

Scores

Biokarpet has an Altman Z-Score of 1.39. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.39
Piotroski F-Score	n/a